Barclays keeps Ares Management and Crocs at Overweight, lifts price targets
Barclays kept Overweight ratings on Ares Management and Crocs and raised their price targets to $151 and $178, according to a TradingView report.
- published on Newsmetry
- original source published
the same feed is available to bots and dashboards through the api. connect the api →
what happened
Barclays kept its Overweight rating on Ares Management and raised its price target from $139 to $151, an 8.6% increase. The new target implies 18.5% upside from the October 29 close of $127.47.
For Crocs, Barclays also maintained Overweight and lifted its target from $139 to $178, a 28.1% rise. That target also implies 18.5% upside, measured from the October 29 close of $150.26. The data comes from TradingView.
why it matters
Target changes like these reflect the view of a single brokerage and mainly interest shareholders of the named companies rather than the broader market. They do not by themselves alter the fundamental picture.
tags
instruments
sources
- Barclays maintains Ares Management at Overweight, raises price target to $151 from $139 — TradingView, 30 October 2026 at 13:49 UTC
- Barclays maintains Crocs at Overweight, raises price target to $178 from $139 — TradingView, 30 October 2026 at 14:14 UTC
- Barclays maintains Incyte at Overweight, raises price target to $143 from $139 — TradingView, 30 October 2026 at 14:36 UTC
- Wells Fargo maintains Ares Management at Overweight, raises price target to $141 from $136 — TradingView, 30 October 2026 at 16:20 UTC
prepared by the newsmetry newsroom with ai assistance from the sources listed below. not investment advice.
alerts on your topics, the morning digest and the api — in your account.
get stories in real time ↗